In spite of the increasing availability of vaccines, affordable and effective treatment options against the deadly SARSs-CoV-2 virus are needed. In a recent study, researchers have shown the efficacy of Artemisinin-based treatment options to be effective against coronavirus in human cell lines including a specific lung cell line. Amidst the rising cases of COVID-19 all over the world in spite of the rampant vaccination programs, there is an immediate requirement to develop anti-viral drugs against this deadly disease. A good strategy to catalyze the process of drug development is repurposing.
Remdesivir is an example of this strategy, however, it stands out to be the only FDA approved drug. With the recent questions on its clinical efficacy, it is quintessential to look out for better alternatives. A new study investigated the anti-malarial medicine Artemisinin, and its related…
